furosemide has been researched along with Hyperparathyroidism, Secondary in 12 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Hyperparathyroidism, Secondary: Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Secondary hyperparathyroidism (SHPT) is a rare complication of furosemide therapy that can occur in patients treated with the loop diuretic for a long period of time." | 7.85 | Successful Reversal of Furosemide-Induced Secondary Hyperparathyroidism With Cinacalcet. ( Alon, US; Jafri, S; Manimtim, WM; Sebestyen VanSickle, J; Srivastava, T; Truog, WE, 2017) |
| "Furosemide induces nephrocalcinosis in both humans and animals." | 7.72 | Effect of the calcimimetic NPS R-467 on furosemide-induced nephrocalcinosis in the young rat. ( Alon, US; Fox, J; Pattaragarn, A, 2004) |
| "Secondary hyperparathyroidism (SHPT) is a rare complication of furosemide therapy that can occur in patients treated with the loop diuretic for a long period of time." | 3.85 | Successful Reversal of Furosemide-Induced Secondary Hyperparathyroidism With Cinacalcet. ( Alon, US; Jafri, S; Manimtim, WM; Sebestyen VanSickle, J; Srivastava, T; Truog, WE, 2017) |
| "Furosemide induces nephrocalcinosis in both humans and animals." | 3.72 | Effect of the calcimimetic NPS R-467 on furosemide-induced nephrocalcinosis in the young rat. ( Alon, US; Fox, J; Pattaragarn, A, 2004) |
| "Hyperuricemia is common among patients with chronic kidney disease (CKD)." | 1.72 | Hyperuricemia is associated with secondary hyperparathyroidism in patients with chronic kidney disease. ( Coelho, VA; Costa, TEM; Elias, RM; Innecchi, MLR; Lauar, JC; Moysés, RMA, 2022) |
| "Vitamin D deficiency is a common risk factor for secondary hyperparathyroidism in nursing home residents despite a climate in which vitamin D nutrition is thought to be ample." | 1.29 | Risk factors for secondary hyperparathyroidism in a nursing home population. ( Ebeling, PR; Flicker, L; Gilbert, RE; Scherer, SC; Stein, MS; Walton, SL; Wark, JD, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Costa, TEM | 1 |
| Lauar, JC | 1 |
| Innecchi, MLR | 1 |
| Coelho, VA | 1 |
| Moysés, RMA | 2 |
| Elias, RM | 3 |
| Srivastava, T | 1 |
| Jafri, S | 1 |
| Truog, WE | 1 |
| Sebestyen VanSickle, J | 1 |
| Manimtim, WM | 1 |
| Alon, US | 2 |
| Vasco, RF | 1 |
| Moyses, RM | 1 |
| Zatz, R | 1 |
| Pattaragarn, A | 1 |
| Fox, J | 1 |
| Tokumoto, T | 1 |
| Tanabe, K | 1 |
| Toma, H | 1 |
| Akiba, T | 1 |
| Khouzam, RN | 1 |
| Dishmon, DA | 1 |
| Farah, V | 1 |
| Flax, SD | 1 |
| Carbone, LD | 1 |
| Weber, KT | 1 |
| Venkataraman, PS | 1 |
| Han, BK | 1 |
| Tsang, RC | 1 |
| Daugherty, CC | 1 |
| Stein, MS | 2 |
| Scherer, SC | 2 |
| Walton, SL | 1 |
| Gilbert, RE | 1 |
| Ebeling, PR | 1 |
| Flicker, L | 2 |
| Wark, JD | 2 |
| Paton, LM | 1 |
| O'Brien, ML | 1 |
| Walton, SC | 1 |
| Chick, P | 1 |
| Di Carlantonio, M | 1 |
| Zajac, JD | 1 |
| Reichel, H | 1 |
| Deibert, B | 1 |
| Geberth, S | 1 |
| Schmidt-Gayk, H | 1 |
| Ritz, E | 1 |
| Coe, FL | 1 |
| Canterbury, JM | 1 |
| Firpo, JJ | 1 |
| Reiss, E | 1 |
1 review available for furosemide and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
[Treatment of bone disease in chronic kidney disease and in renal transplant recipients under K/DOQI clinical practice guidelines].
Topics: Bone Density; Bone Diseases, Metabolic; Calcitonin; Chronic Disease; Diphosphonates; Epoxy Compounds | 2004 |
11 other studies available for furosemide and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
Hyperuricemia is associated with secondary hyperparathyroidism in patients with chronic kidney disease.
Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Calcium; Cholecalciferol; Female; Furosemide; Humans; H | 2022 |
Elderly patients with chronic kidney disease have higher risk of hyperparathyroidism.
Topics: Age Factors; Aged; Aged, 80 and over; Calcium; Cross-Sectional Studies; Diuretics; Female; Furosemid | 2017 |
Successful Reversal of Furosemide-Induced Secondary Hyperparathyroidism With Cinacalcet.
Topics: Calcimimetic Agents; Calcium; Cinacalcet; Furosemide; Humans; Hyperparathyroidism, Secondary; Infant | 2017 |
Furosemide Increases the Risk of Hyperparathyroidism in Chronic Kidney Disease.
Topics: Aged; Aged, 80 and over; Calcium; Diuretics; Female; Furosemide; Humans; Hydrochlorothiazide; Hyperp | 2016 |
Effect of the calcimimetic NPS R-467 on furosemide-induced nephrocalcinosis in the young rat.
Topics: Aniline Compounds; Animals; Calcium; Furosemide; Hyperparathyroidism, Secondary; Kidney; Male; Nephr | 2004 |
Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Diuretics; Female; Furosemide; Heart Failure; | 2006 |
Secondary hyperparathyroidism and bone disease in infants receiving long-term furosemide therapy.
Topics: Bone and Bones; Bone Diseases; Calcium; Furosemide; Humans; Hyperparathyroidism, Secondary; Infant, | 1983 |
Risk factors for secondary hyperparathyroidism in a nursing home population.
Topics: 25-Hydroxyvitamin D 2; Aged; Aged, 80 and over; Australia; Calcium; Female; Furosemide; Hip Fracture | 1996 |
Relationships with serum parathyroid hormone in old institutionalized subjects.
Topics: Aged; Aged, 80 and over; Benzothiadiazines; Body Weight; Cross-Sectional Studies; Diuretics; Female; | 2001 |
Frusemide therapy and intact parathyroid hormone plasma concentrations in chronic renal insufficiency.
Topics: Adult; Aged; Calcium; Furosemide; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; M | 1992 |
Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria.
Topics: Calcium; Creatinine; Female; Furosemide; Humans; Hyperparathyroidism, Secondary; Male; Parathyroid H | 1973 |